Biochemical and Genetic Markers in Aggressiveness and Recurrence of Prostate Cancer: Race-Specific Links to Inflammation and Insulin Resistance

2012 ◽  
Author(s):  
Izabela Podgorski
Keyword(s):  
Prostate Cancer ◽  
Insulin Resistance ◽  
Genetic Markers

530: Termining Risk for Prostate Cancer at Prostate Biopsy using Genetic Markers

2005 ◽  
Vol 173 (4S) ◽  
pp. 144-145
Author(s):  
Robert K. Nam ◽  
William Zhang ◽  
John Trachtenberg ◽  
Michael A.S. Jewett ◽  
Steven Narod
Keyword(s):  
Prostate Cancer ◽  
Genetic Markers ◽  
Prostate Biopsy

New Genetic Markers for Prostate Cancer

2016 ◽  
Vol 43 (1) ◽  
pp. 7-15 ◽  
Author(s):  
Michael S. Leapman ◽  
Peter R. Carroll
Keyword(s):  
Prostate Cancer ◽  
Genetic Markers

scholarly journals Erratum: Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

2018 ◽  
Vol 118 (6) ◽  
pp. e16-e16
Author(s):  
Artitaya Lophatananon ◽  
◽  
Sarah Stewart-Brown ◽  
Zsofia Kote-Jarai ◽  
Ali Amin Al Olama ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Genetic Markers ◽  
Prostate Cancer Risk

Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer

2003 ◽  
Vol 36 (3) ◽  
pp. 303-312 ◽  
Author(s):  
Lisa W. Chu ◽  
Patricia Troncoso ◽  
Dennis A. Johnston ◽  
Jan C. Liang
Keyword(s):  
Prostate Cancer ◽  
Genetic Markers ◽  
Advanced Prostate Cancer ◽  
Locally Advanced ◽  
Locally Advanced Prostate Cancer

Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes

2011 ◽  
Vol 8 (1) ◽  
Author(s):  
George Yu ◽  
Abdulmaged M. Traish
Keyword(s):  
Prostate Cancer ◽  
Insulin Resistance ◽  
Erectile Dysfunction ◽  
Adverse Effects ◽  
Androgen Deprivation Therapy ◽  
Androgen Deprivation ◽  
The Past ◽  
Research Findings ◽  
The Relationship

AbstractOver the past 60 years, androgen deprivation therapy has been the mainstay of treatment of metastatic prostate cancer. However, research findings suggest that androgen deprivation therapy inflicts serious adverse effects on overall health and reduces the quality of life. Among the adverse effects known to date are insulin resistance, diabetes, metabolic syndrome fatigue, erectile dysfunction, and cardiovascular disease. In this clinical perspective, we discuss the relationship between induced androgen deficiency and a host of pathologies in the course of treatment with androgen deprivation therapy for prostate cancer patients.

Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise

2018 ◽  
Vol 19 (7) ◽  
pp. 1008-1016 ◽  
Author(s):  
K. M. Di Sebastiano ◽  
J. H. Pinthus ◽  
W. C. M. Duivenvoorden ◽  
M. Mourtzakis
Keyword(s):  
Prostate Cancer ◽  
Insulin Resistance
Sign in / Sign up

Export Citation Format

Share Document